Stellate Ganglion Block to Treat Long COVID 19 Case Series

Metamorphosis LTD

Status: Completed

Conditions: Fatigue Post Viral; Cough; Menstrual Cycle Abnormal; Brain Fog; Muscle Pain; Long Covid19; Shortness of Breath; Anosmia; Long COVID; Dizziness; Post-COVID-19 Syndrome; Dysgeusia; Post Acute COVID-19 Syndrome; Pain; Dysautonomia

Treatments: Procedure: Stellate Ganglion Block

Study type: Observational

Funder types: Other

Identifiers

NCT05812209

SGBCOVID

Details and patient eligibility

About

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Full description

We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.

Enrollment: 41 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: People who scheduled themselves for a SGB in our clinics in Colorado.

Exclusion Criteria:

Stellate Ganglion Block Contraindications

Trial design

41 participants in 1 patient group

SGB Patients for Long COVID 19

Description:

Patients who received ultrasound guided Stellate Ganglion block for symptoms of Long COVID in our Colorado clinics.

Treatment:

Procedure: Stellate Ganglion Block